Danesi R

References (3)

Title : Clinical pharmacokinetics of irinotecan-based chemotherapy in colorectal cancer patients - Di Paolo_2006_Curr.Clin.Pharmacol_1_311
Author(s) : Di Paolo A , Bocci G , Danesi R , Del Tacca M
Ref : Curr Clin Pharmacol , 1 :311 , 2006
Abstract : Di Paolo_2006_Curr.Clin.Pharmacol_1_311
ESTHER : Di Paolo_2006_Curr.Clin.Pharmacol_1_311
PubMedSearch : Di Paolo_2006_Curr.Clin.Pharmacol_1_311
PubMedID: 18666754

Title : Cholinergic toxic syndrome by the anticancer drug irinotecan: acetylcholinesterase does not play a major role - Blandizzi_2002_Clin.Pharmacol.Ther_71_263
Author(s) : Blandizzi C , Danesi R , De Paolis B , Di Paolo A , Colucci R , Falcone A , Del Tacca M
Ref : Clinical Pharmacology & Therapeutics , 71 :263 , 2002
Abstract : Blandizzi_2002_Clin.Pharmacol.Ther_71_263
ESTHER : Blandizzi_2002_Clin.Pharmacol.Ther_71_263
PubMedSearch : Blandizzi_2002_Clin.Pharmacol.Ther_71_263
PubMedID: 11956509

Title : Acetylcholinesterase blockade does not account for the adverse cardiovascular effects of the antitumor drug irinotecan: a preclinical study - Blandizzi_2001_Toxicol.Appl.Pharmacol_177_149
Author(s) : Blandizzi C , De Paolis B , Colucci R , Di Paolo A , Danesi R , Del Tacca M
Ref : Toxicol Appl Pharmacol , 177 :149 , 2001
Abstract : Blandizzi_2001_Toxicol.Appl.Pharmacol_177_149
ESTHER : Blandizzi_2001_Toxicol.Appl.Pharmacol_177_149
PubMedSearch : Blandizzi_2001_Toxicol.Appl.Pharmacol_177_149
PubMedID: 11740913